Form 8-K - Current report:
SEC Accession No. 0001493152-21-010348
Filing Date
2021-05-03
Accepted
2021-05-03 17:00:18
Documents
14
Period of Report
2021-05-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59215
2 ex99-1.htm EX-99.1 45846
3 ex99-1_001.jpg GRAPHIC 6763
  Complete submission text file 0001493152-21-010348.txt   304932

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lctx-20210503.xsd EX-101.SCH 3196
5 XBRL LABEL FILE lctx-20210503_lab.xml EX-101.LAB 34592
6 XBRL PRESENTATION FILE lctx-20210503_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3618
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 21884458
SIC: 2836 Biological Products, (No Diagnostic Substances)